Successful Start of InnoCAR-T Training Network: Apply for Ten PhD Positions!

Note! ALL POSTIONS ARE CLOSED!

The Marie Curie European Doctoral Network (DN) InnoCAR-T successfully started on 1 January 2023. Funded by the European Commission within the Horizon Europe Research and Innovation Action, the InnoCAR-T programme aims to develop innovative Chimeric Antigen Receptor (CAR) T cell therapy solutions for Point-of-Care localised manufacturing. To this end, InnoCAR-T exploits state-of-the-art industrial manufacturing and gene-editing technology combined with academic CAR-T concepts and datasets.

The network comprises three academic research institutes/universities and two companies based in the Netherlands, Belgium and Spain. They are now recruiting ten highly motivated PhD candidates interested in carrying out breakthrough research on the rapidly expanding and high-impact field of CAR-T cancer immunotherapy. Doctoral Candidates (DC) will crucially gain intersectoral experience in their individual research projects, with an academic and an industrial part.

The ten InnoCAR-T PhD research projects provide an integrated and interconnected research programme focused on developing next-generation CAR-T cell therapeutics that will be produced on-site by academic hospitals. Specifically, the team strives to come up with innovative manufacturing solutions for Point-of-Care CAR-T production. Secondly, the partners seek to characterise resistance mechanisms to CAR-T therapy in B cell lymphoma and develop (multiplexed) gene-engineered and/or nanoparticle-modified CAR-T formulations to selectively overcome the immunosuppressive tumour micro environment.

Find out all the details about the projects and application procedure here.